CHINA JO-JO DRUGSTORES, INC. (NASDAQ:CJJD) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On March 4, 2019, China Jo-Jo Drugstores, Inc. issued a press release in the form of an open letter to its shareholders outlining its corporate strategy for 2019. The full text of the press release is furnished herein as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
The following is furnished as an exhibit to this report:
CHINA JO-JO DRUGSTORES, INC. Exhibit
EX-99.1 2 f8k030419ex99-1_chinajojo.htm PRESS RELEASE (LETTER TO SHAREHOLDERS),…
To view the full exhibit click here
About CHINA JO-JO DRUGSTORES, INC. (NASDAQ:CJJD)
China Jo-Jo Drugstores, Inc. is a retailer and distributor of pharmaceutical and other healthcare products found in a retail pharmacy in the People’s Republic of China. The Company’s segments include retail drugstores, online pharmacy, drug wholesale and herb farming. The retail drugstores segment sells prescription and over-the-counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplement, medical devices and sundry items to retail customers. Its online pharmacy segment sells OTC drugs, dietary supplement, medical devices and sundry items to customers through Alibaba’s Tmall and its own platform all over China. The drug wholesale segment supplies its own retail drugstores with prescription and OTC medicines, TCM, dietary supplement, medical devices and sundry items, and also sells them to other drug vendors and hospitals. Its herb farming segment cultivates selected herbs for sales to other drug vendors. It is also involved in online sales and clinic services.